M. Spielmann
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Lesions and Carcinomas, Lung Cancer Treatments and Mutations
Most-Cited Works
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.(1998)
- → Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial(2006)571 cited
- → Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer(1989)567 cited
- → Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period(2004)396 cited
- → Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.(1996)383 cited
- → Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials(2021)332 cited
- → Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review(2011)315 cited
- → Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial(2009)298 cited
- → Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer(2005)283 cited
- → Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-Up(2003)218 cited